ALPENGLOW BIOSCIENCES, INC. — Department of Health and Human Services STTR Phase I: 102

ALPENGLOW BIOSCIENCES, INC. — STTR Phase I award from Department of Health and Human Services.

Amount
$398,305
Agency
Department of Health and Human Services · National Institutes of Health
Program / Phase
STTR · Phase I
Topic
102
Solicitation
PA20-265
NAICS
Place of performance
WA
Period
2021-07-01 → 2022-06-30

Description

Abstract (300 words maximum) Each year, over 700 women undergo an image-guided core needle biopsy (CNB) to evaluate a suspicious breast finding at the Seattle Cancer Care Alliance, with only about 30% biopsies yielding malignancy. Typical turnaround time for determination of the presence or absence of cancer from CNBs is three to five business days, and this waiting time can lead to avoidable anxiety and delays in management. Our team has pioneered the use of open-top light-sheet microscopy (OTLS), which is a slide-free fluorescence imaging technique that enables rapid, large area scanning of fresh tissue. A preliminary study using excised 1 cm2 pieces of fresh breast tissue showed that OTLS imaging can provide diagnostic quality images in under 10 minutes. We hypothesize that OTLS evaluation of CNB breast tissue specimens will provide an accurate determination of malignancy vs. no malignancy within 30 minutes of obtaining breast core specimens. We will test this hypothesis by optimizing evaluation of CNB samples with OTLS using breast cancers that have been excised surgically and then testing its accuracy in a small clinical trial of 40 women. If successful, our approach could allow women with concerning breast imaging findings to have a complete imaging and pathology workup in the same day, leading to reassurance in the majority of women and earlier triage to appropriate care in those with breast cancer. Furthermore, wider application of this technology could allow for more accurate whole-specimen evaluation of biomarkers of disease, such as quantification of tumor infiltrating lymphocytes, and more elegant radiology-pathology correlation studies that could advance the emerging fields of radiomics and pathomics.Narrative Breast cancer is common, accounting for approximately 40,000 deaths among U.S. women each year. The current chain of events for diagnosing breast cancer (screening, diagnostic mammography, biopsy, and pathology) can require weeks, causing avoidable anxiety and delays in treatment for women with breast cancer. We propose workflow, aided by novel open- top light-sheet microscopy, for same day end-to-end breast cancer diagnostics.